BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
Get Our Industry eNewsletter FREE email:    
   

Harvest Technologies Corporation Files Patent Infringement Complaint Against ThermoGenesis (KOOL)


10/25/2012 10:31:07 AM

PLYMOUTH, Mass., Oct. 24, 2012 /PRNewswire/ -- Harvest Technologies Corporation (Harvest) announced that it filed a patent infringement complaint on October 24, 2012 in the US District Court of Delaware against ThermoGenesis Corporation (ThermoGenesis). The complaint alleges that ThermoGenesis' Res-Q 60 BMC system (*also known as ART 21®) infringes two patents for which Harvest Technology owns the rights. These patents relate to Harvest's proprietary floating shelf technology that has been shown in studies to provide superior cellular concentration. The complaint also requests an injunction against further sales of the product in the U.S.

"Harvest Technologies respects the valid intellectual property of others and expects that its competitors will do the same. Harvest has invested millions of dollars in development of its cellular therapy products for many years and cannot allow others to profit by our innovations," said Gary Tureski, President and CEO, Harvest Technologies Corporation.

Harvest Technologies is the leading Cellular Therapy global manufacturer that has developed point-of-care products to process and concentrate multiple biologics. These include high-density platelet rich plasma (APC+®), bone marrow aspirate concentrate (BMAC®) and adipose tissue. The company is headquartered in Plymouth, Massachusetts. It is one of several subsidiaries of Terumo Corporation of Japan that is focused in cellular therapies and biologics. For more information, visit www.harvesttech.com or call 508-732-7500.

Tokyo-based Terumo Corporation is one of the world's leading medical device manufacturers with $5 billion in sales and operations in more than 160 nations. Founded in 1921, the company develops, manufactures, and distributes world-class medical devices including products for use in cardiothoracic surgery, interventional procedures, and transfusion medicine; the company also manufactures a broad array of syringe and hypodermic needle products for hospital and physician office use.

Harvest is a registered trademark of Harvest Technologies Corporation. Terumo® is a registered trademark of Terumo Corporation. Res-Q is a trademark of ThermoGenesis Corporation.

*ART 21 is a trademark of Celling Technologies®

SOURCE Harvest Technologies Corporation


Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES
 

//-->